Opportunity
SAM #N0018926QB041
DoD Solicitation for FDA-Cleared THC9-COOH Immunoassay Reagent Kits for Beckman Coulter AU5800
Buyer
NAVSUP FLC Norfolk
Posted
April 16, 2026
Respond By
May 15, 2026
Identifier
N0018926QB041
NAICS
325413
This opportunity involves supplying FDA-cleared THC9-COOH immunoassay reagent kits for the Department of Defense Drug Demand Reduction Program, administered by NAVSUP Fleet Logistics Center Norfolk. - Government Buyer: - Department of Defense, NAVSUP Fleet Logistics Center Norfolk (NAVSUP FLT LOG CTR NORFOLK) - OEM Highlight: - Beckman Coulter is the required OEM; all reagent kits must be compatible with Beckman Coulter AU5800 Series Clinical Chemistry Analyzers - Vendors: - Beckman Coulter (OEM/manufacturer) - Products/Services Requested: - Up to 30,000,000 FDA-cleared, Quality Management Documented THC9-COOH immunoassay reagent kits - For detection of delta-9-tetrahydrocannabinol-11-carboxylic acid (THC9-COOH) in human urine - Kits must be compatible with Beckman Coulter AU5800 series analyzers - No specific part numbers provided - Unique/Notable Requirements: - Kits must meet strict DoD forensic toxicology lab performance, quality, and packaging standards - OEM compliance and FDA approval are mandatory - Delivery to multiple DoD forensic toxicology labs across Navy, Air Force, Army, and Armed Forces Medical Examiner System locations - Place of Performance/Delivery Locations: - Navy Drug Screening Laboratory, Great Lakes, IL - Navy Drug Screening Laboratory, Naval Air Station Jacksonville, FL - Headquarters Air Force Drug Testing Laboratory, Lackland Air Force Base, TX - Army Forensic Toxicology Drug Testing Laboratory, Fort Meade, MD - Army Forensic Toxicology Drug Testing Laboratory Pacific Contracting Center, Fort Shafter Flats, HI - Armed Forces Medical Examiner System, Dover Air Force Base, DE
Description
The Department of War (DOW) Drug Demand Reduction Program (DDRP) has a requirement for FDA and Quality Management Documented THC9-COOH immunoassay reagent kits for use with the currently installed Beckman Coulter AU5800 series systems. The reagents shall be capable of detecting THC9-COOH in human urine samples.